Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study

BACKGROUND AND OBJECTIVES: Prolonged use of calcineurin inhibitors (CNIs) in kidney transplant recipients is associated with renal and nonrenal toxicity and an increase in cardiovascular risk factors. Belatacept-based regimens may provide a treatment option for patients who switch from CNI-based mai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rostaing, Lionel, Massari, Pablo, Garcia, Valter Duro, Mancilla-Urrea, Eduardo, Nainan, Georgy, del Carmen Rial, Maria, Steinberg, Steven, Vincenti, Flavio, Shi, Rebecca, Di Russo, Greg, Thomas, Dolca, Grinyó, Josep
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3052236/
https://ncbi.nlm.nih.gov/pubmed/21051752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05840710
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados